The most commonly used compounds for contrast enhancement are gadolinium-based. MRI contrast agents alter the relaxation times of atoms within body tissues where they are present after oral or intravenous administration.
Contrast enhancement is a crucial radiologic feature of malignant brain tumors, which are associated with genetic changes of the tumor.